Datroway (datopotamab deruxtecan) is the first TROP2-directed therapy approved for advanced lung cancer in the U.S.

Expansion plans for the Leicester Royal Infirmary (LRI) have emerged in a bid to meet a growing need for cancer treatment.

Cambridge Healthcare Innovations (CHI) announced the availability of its dry powder inhaler (DPI) engine for clinical trials ...

Over the past few years, glutathione has surged in popularity, especially after making a mark in Indian pop culture through ...

Revumenib, an oral targeted therapy for rare leukemias, is projected to be cost-neutral for health plans over 3 years, ...

A man has shared how his beloved husband died after flu-like symptoms turned out to be deadly cancer. Brendan Hulse-Lewis had ...

The current clinical evidence of intravenous glutathione for skin lightening is limited. In most countries, IV glutathione is approved only for severe liver disorders and for prevention of ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA ...

Actor Shefali Jariwala's sudden death has put a spotlight on the anti-ageing treatments in India. Doctors warn about serious ...

Cambridge Healthcare Innovations (CHI), a start-up designing and licensing revolutionary inhaler technology, has unveiled ...

On June 15 last year Kate, The Princess of Wales really put the ‘trooper’ into Trooping the Colour and appeared at the annual celebration of the sovereign’s birthday, despite being in the middle of ...